Methamphetamine Dependency. Other psychoactive substance related disorders
Conditions
Interventions
Intervention 1: We will use Buprenorphine 0.1 mg po QD for one group at least 14 days. Intervention 2: We will use Buprenorphine 8 mg po QD for one group at least 14 days. Intervention 3: We will use
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1)Age 18-50 2) inform consent 3)methamphetamine depanced
Exclusion criteria
Exclusion criteria: 1)patient unwilling to participle at beginning or during the study, 2)use of another substance except Methamphetamine as of the main substance
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Craving. Timepoint: Before starting the intervention and daily for 4 days after starting the drug. Method of measurement: Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Depression. Timepoint: Before starting the intervention and daily for 4 days after starting the drug. Method of measurement: Questionnaire.;Suicide. Timepoint: Before starting the intervention and daily for 4 days after starting the drug. Method of measurement: Questionnaire.;Anxiety. Timepoint: Before starting the intervention and daily for 4 days after starting the drug. Method of measurement: Questionnaire.;Withdrawal. Timepoint: Before starting the intervention and daily for 4 days after starting the drug. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir Bazrafshan M.D
Shiraz University of Medical Sciences
Outcome results
None listed